欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2021, Vol. 26 ›› Issue (7): 808-813.doi: 10.12092/j.issn.1009-2501.2021.07.013

• 综述与讲座 • 上一篇    下一篇

药物干预近视眼发生发展的研究现状

王甜甜1,2,张荣荣1,吴昌凡1   

  1. 1皖南医学院弋矶山医院眼科,芜湖 241001,安徽;2马鞍山十七冶医院眼科,马鞍山 243000,安徽
  • 收稿日期:2021-03-30 修回日期:2021-04-09 出版日期:2021-07-26 发布日期:2021-08-09
  • 通讯作者: 吴昌凡,男,硕士,主任医师,教授,研究方向:屈光不正与眼底病。 Tel: 13909632351 E-mail: wucangfan@sina.com
  • 作者简介:王甜甜,女,硕士,住院医师,研究方向:屈光不正与眼底病。 Tel: 19955518786 E-mail: oph_wtt@163.com
  • 基金资助:
    安徽省卫生健康委科研项目(AHWJ2021b120)

Current research of drug interventions in the occurrence and development of myopia

WANG Tiantian 1,2, ZHANG Rongrong 1, WU Changfan 1   

  1. 1 Department of Ophthalmology, Yijishan Hospital of Wannan Medical College, Wuhu 241001, Anhui, China
  • Received:2021-03-30 Revised:2021-04-09 Online:2021-07-26 Published:2021-08-09

摘要: 近视是儿童及青少年最为常见的眼部疾病。随着近视和高度近视的患病率逐年增加,高度近视及其并发症所导致的低视力及致盲的人数也逐渐增加。但近视的发生和发病机理目前并不清楚,现有的干预方法有光学和药物等措施。本文旨在总结近年来在临床和动物试验期方面讨论药物干预近视的研究进展。

关键词: 近视, 药物干预, 临床和动物试验

Abstract: Myopia is the most common eye disease occurring in children and adolescents. As the prevalence rates of myopia and high myopia have increased yearly, the number of individuals with low vision and blindness caused by high myopia and its complications has gradually increased. However, the mechanisms underlying the occurrence and development of myopia are currently unclear. The existing intervention methods include optical and drug measures. This article summarizes the measures implemented for the prevention and control of myopia in recent years and discusses the research progress of drug interventions for myopia, considering the aspects of clinical and animal trials.

Key words: myopia, drug interventions, clinical and animal trials

中图分类号: